3T Biosciences to Present at BIO CEO & Investor Digital Conference
John Connolly, Ph.D., interim CEO, and Hanspeter Gerber, Ph.D., Chief Scientific Officer, will participate in the BIO CEO & Investor Digital Conference, February 16-18, 2021. Dr. Connolly, will present an overview of the company and 3T-TRACE, a technology that applies a yeast display platform and…